RICHTER logo

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Stock Price

Symbol: BUSE:RICHTERMarket Cap: Ft1.9tCategory: Pharmaceuticals & Biotech

RICHTER Share Price Performance

RICHTER Community Fair Values

    Recent RICHTER News & Updates

    No updates

    Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Key Details

    Ft878.1b

    Revenue

    Ft274.4b

    Cost of Revenue

    Ft603.7b

    Gross Profit

    Ft364.5b

    Other Expenses

    Ft239.2b

    Earnings

    Last Reported Earnings
    Mar 31, 2025
    Next Reporting Earnings
    Aug 06, 2025
    Earnings per share (EPS)
    1.31k
    Gross Margin
    68.75%
    Net Profit Margin
    27.24%
    Debt/Equity Ratio
    4.8%

    Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About RICHTER

    Founded
    1901
    Employees
    10943
    CEO
    Gabor Orban
    WebsiteView website
    www.gedeonrichter.com

    Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products in Europe, the Asia Pacific, North and Latin America, and internationally. It operates through two segments, Pharmaceuticals; and Wholesale and Retail. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. The company was formerly known as Gedeon Richter Ltd. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.

    Hungarian Market Performance

    • 7 Days: -0.3%
    • 3 Months: 4.3%
    • 1 Year: 28.0%
    • Year to Date: 14.8%
    Over the last 7 days, the market has remained flat, although notably the Materials sector gained 13% in that time. More promisingly, the market is up 28% over the past year. Earnings are forecast to grow by 4.2% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading